back
SEDI Insider filing browser
| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2021-07-26 10:58 Tx date 2021-07-20 |
$KNE
Kane Biotech Inc. |
Mandelzys, Allan
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units
56 - Grant of rights
|
+500,000 vol |
500,000 | |
| Filed 2021-07-26 10:53 Tx date 2021-05-26 |
$KNE
Kane Biotech Inc. |
Mandelzys, Allan
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2019-04-22 10:45 Tx date 2019-04-17 |
$CMTA
Clementia Pharmaceuticals Inc. |
Mandelzys, Allan
4 - Director of Issuer
Direct Ownership
|
Rights DSU (Deferred Share Units)
59 - Exercise for cash
|
$-298,375
-11,935 vol $25.00 each |
0 | |
| Filed 2019-04-22 10:44 Tx date 2019-04-17 |
$CMTA
Clementia Pharmaceuticals Inc. |
Mandelzys, Allan
4 - Director of Issuer
Direct Ownership
|
Options
59 - Exercise for cash
|
-142,681 vol |
0 | |
| Filed 2019-04-22 10:43 Tx date 2019-04-17 |
$CMTA
Clementia Pharmaceuticals Inc. |
Mandelzys, Allan
4 - Director of Issuer
Direct Ownership
|
Common Shares
22 - Acquisition or disposition pursuant to a take-over bid, merger or acquisition
|
$-1,468,775
-58,751 vol $25.00 each |
0 | |
| Filed 2019-03-01 Tx date 2019-02-24 |
$CMTA
Clementia Pharmaceuticals Inc. |
Mandelzys, Allan
4 - Director of Issuer
Direct Ownership
|
Rights DSU (Deferred Share Units)
56 - Grant of rights
|
+7,845 vol |
11,935 | |
| Filed 2019-01-04 Tx date 2018-12-31 |
$CMTA
Clementia Pharmaceuticals Inc. |
Mandelzys, Allan
4 - Director of Issuer
Direct Ownership
|
Rights DSU (Deferred Share Units)
56 - Grant of rights
|
+1,062 vol |
4,090 | |
| Filed 2018-11-29 Tx date 2018-11-06 |
$CMTA
Clementia Pharmaceuticals Inc. |
Mandelzys, Allan
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+11,990 vol |
142,681 | |
| Filed 2018-10-04 Tx date 2018-09-30 |
$CMTA
Clementia Pharmaceuticals Inc. |
Mandelzys, Allan
4 - Director of Issuer
Direct Ownership
|
Rights DSU (Deferred Share Units)
56 - Grant of rights
|
+1,121 vol |
3,028 | |
| Filed 2018-07-04 Tx date 2018-06-30 |
$CMTA
Clementia Pharmaceuticals Inc. |
Mandelzys, Allan
4 - Director of Issuer
Direct Ownership
|
Rights DSU (Deferred Share Units)
56 - Grant of rights
|
+1,021 vol |
1,907 | |
| Filed 2018-04-17 Tx date 2017-08-14 |
$CMTA
Clementia Pharmaceuticals Inc. |
Mandelzys, Allan
4 - Director of Issuer
Direct Ownership
|
Rights DSU (Deferred Share Units)
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2018-04-17 Tx date 2017-08-14 |
$CMTA
Clementia Pharmaceuticals Inc. |
Mandelzys, Allan
4 - Director of Issuer
Direct Ownership
|
Rights DSU (Deferred Share Units)
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2018-04-17 Tx date 2018-03-31 |
$CMTA
Clementia Pharmaceuticals Inc. |
Mandelzys, Allan
4 - Director of Issuer
Direct Ownership
|
Rights DSU (Deferred Share Units)
56 - Grant of rights
|
+886 vol |
||
| Filed 2018-04-17 Tx date 2018-03-31 |
$CMTA
Clementia Pharmaceuticals Inc. |
Mandelzys, Allan
4 - Director of Issuer
Direct Ownership
|
Rights DSU (Deferred Share Units)
56 - Grant of rights
|
+886 vol |
||
| Filed 2018-04-17 Tx date 2018-03-31 |
$CMTA
Clementia Pharmaceuticals Inc. |
Mandelzys, Allan
4 - Director of Issuer
Direct Ownership
|
Rights DSU (Deferred Share Units)
56 - Grant of rights
|
+886 vol |
886 | |
| Filed 2018-04-17 Tx date 2017-08-14 |
$CMTA
Clementia Pharmaceuticals Inc. |
Mandelzys, Allan
4 - Director of Issuer
Direct Ownership
|
Rights DSU (Deferred Share Units)
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2018-04-16 Tx date 2017-08-14 |
$CMTA
Clementia Pharmaceuticals Inc. |
Mandelzys, Allan
4 - Director of Issuer
Direct Ownership
|
Rights DSU (Deferred Share Units)
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2018-04-16 Tx date 2018-03-31 |
$CMTA
Clementia Pharmaceuticals Inc. |
Mandelzys, Allan
4 - Director of Issuer
Direct Ownership
|
Rights DSU (Deferred Share Units)
56 - Grant of rights
|
+886 vol |
886 | |
| Filed 2017-08-23 Tx date 2017-08-14 |
$CMTA
Clementia Pharmaceuticals Inc. |
Mandelzys, Allan
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
130,691 | ||
| Filed 2017-08-23 Tx date 2017-08-14 |
$CMTA
Clementia Pharmaceuticals Inc. |
Mandelzys, Allan
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
58,751 |